Quantbot Technologies’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,600
Closed -$11.1K 1860
2023
Q1
$11.1K Buy
+3,600
New +$13.6K ﹤0.01% 1406
2022
Q4
Sell
-4,489
Closed -$10K 2007
2022
Q3
$10K Buy
4,489
+1,820
+68% +$5.31K ﹤0.01% 1424
2022
Q2
$7K Sell
2,669
-3,600
-57% -$8.95K ﹤0.01% 1563
2022
Q1
$18K Sell
6,269
-8,200
-57% -$21.2K ﹤0.01% 1380
2021
Q4
$43K Buy
+14,469
New +$62.8K ﹤0.01% 1062
2020
Q4
Sell
-2,670
Closed -$26K 1586
2020
Q3
$26K Buy
2,670
+2,550
+2,125% +$26K ﹤0.01% 985
2020
Q2
$1K Buy
+120
New +$1.24K ﹤0.01% 1071
2019
Q3
Sell
-5,600
Closed -$71K 1484
2019
Q2
$71K Buy
+5,600
New +$129K 0.01% 829
2017
Q2
Sell
-748
Closed -$27K 1310
2017
Q1
$27K Buy
+748
New +$27.3K ﹤0.01% 978
2016
Q4
Sell
-4,424
Closed -$296K 1280
2016
Q3
$296K Sell
4,424
-1,743
-28% -$88.1K 0.03% 468
2016
Q2
$183K Buy
+6,167
New +$193K 0.02% 590
2015
Q3
Sell
-800
Closed -$93K 1363
2015
Q2
$93K Buy
+800
New +$145K 0.02% 657
2014
Q2
Sell
-200
Closed -$20K 1330
2014
Q1
$20K Sell
200
-100
-33% -$11.8K ﹤0.01% 959
2013
Q4
$31K Buy
+300
New +$17.6K 0.02% 709

Other funds holding PBYI

Quantbot Technologies's PBYI Position: Q2 2023 in Review

Quantbot Technologies sold out of Puma Biotechnology (PBYI) in Q2 2023, closing a stake of 3,600 shares — an estimated $11.1K sold.

Quantbot Technologies first reported a position in PBYI in Q4 2013 and held it in 14 quarters. The position peaked at $296K in Q3 2016. 68 funds tracked by Wall St. Rank hold PBYI as of Q2 2023.

  • Quantbot Technologies reported no remaining Puma Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 3,600 Puma Biotechnology shares in Q2 2023, an estimated $11.1K.
  • Quantbot Technologies first reported a position in Puma Biotechnology in Q4 2013 and held it in 14 quarters.
  • Quantbot Technologies's Puma Biotechnology position peaked at $296K in Q3 2016.
  • 68 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.